Trial
NCT03648372
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Takeda
Collaborators
—
Condition
Neoplasms
Intervention
TAK-981
Why stopped
Enrolment Challenges
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-19